切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2016, Vol. 04 ›› Issue (04) : 284 -287. doi: 10.3877/cma.j.issn.2095-655X.2016.04.018

所属专题: 文献

综述

高迁移率族蛋白B1在缺血性脑卒中的作用及研究进展
金聪丽1, 周海红1,()   
  1. 1. 524023 湛江,广东医学院附属医院神经内科
  • 收稿日期:2016-05-18 出版日期:2016-11-26
  • 通信作者: 周海红
  • 基金资助:
    广东省科技计划项目(2011B031800390)

Progress of high mobility group box B1 and its relationship in stroke

Congli Jin1, Haihong Zhou1,()   

  1. 1. Department of Neurology, the Affiliated Hospital of Guangdong Medical College, Zhanjiang 524023, China
  • Received:2016-05-18 Published:2016-11-26
  • Corresponding author: Haihong Zhou
  • About author:
    Corresponding author: Zhou Haihong, Email:
引用本文:

金聪丽, 周海红. 高迁移率族蛋白B1在缺血性脑卒中的作用及研究进展[J/OL]. 中华诊断学电子杂志, 2016, 04(04): 284-287.

Congli Jin, Haihong Zhou. Progress of high mobility group box B1 and its relationship in stroke[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(04): 284-287.

脑卒中后预后很大程度受炎症的影响,高迁移率族蛋白B1(HMGB1)作为促炎因子,参与了神经系统疾病的发生发展,其中在缺血性脑卒中,HMGB1贯穿动脉粥样硬化形成、脑卒中发生、脑卒中修复整个过程,并扮演着了不同的角色。HMGB1通过增加内皮通透性,促炎作用以及促进平滑肌迁移等参与了动脉粥样硬化发展。坏死神经元释放的HMGB1不仅反向导致神经元的坏死,并且作为危险相关分子模式(DAMP)分子放大炎症反应。然而星形胶质细胞通过释放HMGB1增加内源性内皮组细胞(EPCs)的活力,促进脑卒中后的神经血管修复。笔者就HMGB1的结构、功能以及缺血性脑卒中的作用及研究进展做一综述。

Inflammatory cascades have a major impact on outcome and regeneration after ischemic stroke.High mobility group box B1 (HMGB1), a pro-inflammatory cytokine, contributes to the development of atherosclerosis, ischemic brain injury, and neurovascular repair.Meanwhile, it plays a very different role in stroke.HMGB1 participates in progression of atherosclerosis through vascular endothelial hyperpermeability, harmful inflammatory response and migration of smooth muscle cells.HMGB1 is released by necrotic neuronal cells, not only reverses to injury neuronal cell, but as danger-associated molecular patterns (DAMP) to amplify inflammatory response.On the other hand, astrocyte-derived HMGB1 induces the promotion of endogenous EPCs viability and enhances neurovascular repair in post-ischemic.This review mainly focuses on the present research of HMGB1 structure, functions and relationship in stroke.

[1]
Goodwin GH,Sanders C,Johns EW.A new group of chromatin-associated proteins with a high content of acidic and basic amino acids[J]. Eur J Biochem, 1973, 38(1): 14-19.
[2]
Wang FC,Pei JX,Zhu J, et al.Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro[J]. World J Gastroenterol, 2015, 21(25): 7764-7776.
[3]
戚之琳,齐世美,凌烈锋, 等. 瑞香素对HMGB1释放及HMGB1诱发的炎症反应的双重抑制作用[J]. 南方医科大学学报, 2015, 35(11): 1519-1523.
[4]
Liu M,Yu Y,Jiang H, et al.Simvastatin suppresses vascular inflam mation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis[J]. Acta Pharmacol Sin, 2013, 34(6): 830-836.
[5]
Umahara T,Uchihara T,Koyama S, et al.Local extension of HMGB1 in atherosclerotic lesions of human main cerebral and carotid arteries[J]. Histol Histopathol, 2014, 29(2): 235-242.
[6]
de Souza AW,Westra J,Limburg PC, et al.HMGB1 in vascular diseases:Its role in vascular inflammation and atherosclerosis[J]. Autoimmun Rev, 2012, 11(12): 909-917.
[7]
Libby P. Inflammation in atherosclerosis[J]. Nature, 2002, 420(6917): 868-874.
[8]
Yan XX,Lu L,Peng WH, et al.Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients[J]. Atherosclerosis, 2009, 205(2): 544-548.
[9]
Chen J,Zhang J,Xu L, et al.Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor[J]. Atherosclerosis, 2012, 224(2): 332-339.
[10]
Vogel S,Bodenstein R,Chen Q, et al.Platelet-derived HMGB1 is a critical mediator of thrombosis[J]. J Clin Invest, 2015, 125(12): 4638-4654.
[11]
Moreno JA,Sastre C,Madrigal-Matute J, et al.HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in ather osclerotic plaques and cultured monocytes[J]. Arterioscler Thromb Vasc Biol, 2013, 33(3): 612-620.
[12]
Hu N,Kong L,Qian A, et al.HMGB1 silencing potentiates the anti-inflammatory effects of sodium ferulate in ox-LDL-Stimulated vascular smooth muscle cells[J]. Cell Biochem Biophys, 2015, 72(1): 297-304.
[13]
Inoue K,Kawahara K,Biswas KK, et al.HMGB1 expression by activated vascular smooth muscle cells in advanced human athero sclerosis plaques[J]. Cardiovasc Pathol, 2007, 16(3): 136-143.
[14]
Zou M,Dong H,Meng X, et al.Store-operated Ca2+ entry plays a role in HMGB1-induced vascular endothelial cell hyperpermeability[J]. PLoS One, 2015, 10(4): e0123432.
[15]
Kanellakis P,Agrotis A,Kyaw TS, et al.High-mobility group box protein 1 neutralization reduces development of diet-induced ather osclerosis in apolipoprotein e-deficient mice[J]. Arterioscler Thromb Vasc Biol, 2011, 31(2): 313-319.
[16]
Bruchfeld A,Wendt M,Bratt J, et al.High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations[J]. Mol Med, 2011, 17(1-2): 29-35.
[17]
Hoshina T,Kusuhara K,Ikeda K, et al..High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease[J]. Scand J Rheumatol, 2008, 37(6): 445-449.
[18]
Taira T,Matsuyama W,Mitsuyama H, et al.Increased serum high mobility group box-1 level in Churg-Strauss syndrome[J]. Clin Exp Immunol, 2007, 148(2): 241-247.
[19]
Sapojnikova N,Kartvelishvili T,Asatiani N, et al.Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome[J]. Biochim Biophys Acta, 2014, 1842(9): 1379-1384.
[20]
Yang QW,Lu FL,Zhou Y, et al.HMBG1 mediates ischemia-reper fusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling[J]. J Cereb Blood Flow Metab, 2011, 31(2): 593-605.
[21]
Liesz A,Dalpke A,Mracsko E, et al.DAMP signaling is a key pathway inducing immune modulation after brain injury[J]. J Neurosci, 2015, 35(2): 583-598.
[22]
Menini T,Ikeda H,Kimura S, et al.Circulating soluble RAGE increase after a cerebrovascular event[J]. Clin Chem Lab Med, 2014, 52(1): 109-116.
[23]
Zhai DX,Kong QF,Xu WS, et al.RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats[J]. Neurosci Lett, 2008, 445(1): 117-121.
[24]
Zhang J,Wu Y,Weng Z, et al.Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway[J]. Brain Res, 2014(1582): 176-186.
[25]
Muhammad S,Barakat W,Stoyanov S, et al.The HMGB1 receptor RAGE mediates ischemic brain damage[J]. J Neurosci, 2008, 28(46): 12023-12031.
[26]
Qiu J,Xu J,Zheng Y, et al.High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia[J]. Stroke, 2010, 41(9): 2077-2082.
[27]
赵丽丽,程小军,陈珩, 等. 缺血性脑卒中患者颈部血管狭窄的诊断及介入治疗[J/CD]. 中华诊断学电子杂志, 2014, 2(1): 17-23.
[28]
Borlongan CV,Glover LE,Tajiri N, et al.The great migration of bone marrow-derived stem cells toward the ischemic brain:therapeutic implications for stroke and other neurological disorders[J]. Prog Neurobiol, 2011, 95(2): 213-228.
[29]
Hayakawa K,Pham LD,Katusic ZS, et al.Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neuro vascular remodeling during stroke recovery[J]. Proc Natl Acad Sci U S A, 2012, 109(19): 7505-7510.
[30]
Schlueter C,Weber H,Meyer B, et al.Angiogenetic signaling through hypoxia:HMGB1:an angiogenetic switch molecule[J]. Am J Pathol, 2005, 166(4): 1259-1263.
[31]
Treutiger CJ,Mullins GE,Johansson AS, et al.High mobility group 1 B-box mediates activation of human endothelium[J]. J Intern Med, 2003, 254(4): 375-385.
[1] 马晓菊, 梁潇, 段云友, 袁丽君, 赵萍. NBAV脂质纳泡对ApoE -/-小鼠动脉粥样硬化病变的评估和干预[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 608-616.
[2] 张怡, 王宇洋, 司梦娇, 曹燕, 李欢欢. 脑卒中前白蛋白与肺炎发生风险相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 648-651.
[3] 江西省神经外科质量控制中心. 江西省心源性脑卒中多学科协作防治专家共识[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 264-277.
[4] 张洪, 杨琪, 罗静, 唐茜, 邓鸿, 巩文艳, 王丽坤, 刘静, 艾双春. 多靶点神经调控技术对卒中后上肢运动功能障碍患者的脑网络功能连接研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 278-284.
[5] 许方军, 曹晓光, 王修敏, 王婷, 陈冬冬, 余程冬, 张鹤言. 基于闭环理论的动作观察疗法联合躯干控制训练对脑卒中后下肢运动的影响[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 292-299.
[6] 张雅文, 尹昱, 陈江龙, 杨玉慧, 吕红香, 张琦, 吕佩源. Theta爆发式经颅磁刺激治疗失语症的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 306-311.
[7] 陈冬冬, 余程冬, 曹晓光. 上肢外骨骼机器人在脑卒中康复中的应用与研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 312-317.
[8] 石佳娜, 钱琳艳, 姬凯悦, 祁金文, 胡情, 孙佳斌. 从PVAT 白色脂肪棕色化角度探讨中药在防治动脉粥样硬化中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 853-858.
[9] 温绍敏, 王雅晳, 施依璐, 段莎莎, 云书荣, 张小杉. 靶向超声造影技术在动脉粥样硬化治疗中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 496-499.
[10] 李璇, 邓岚, 郭微, 邓永梅, 刘杰昕. 标准化皮肤管理流程在防治脑卒中患者失禁相关性皮炎中的应用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 479-482.
[11] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[12] 王丽娜, 吕书霞, 李亚男. 脑卒中偏瘫患者健康焦虑元认知与疾病接受度、恐惧疾病进展的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 434-440.
[13] 周洪千, 张煜坤, 顾天舒, 胡苏涛, 姜超, 张雪, 张昊, 陶华岳, 刘行, 刘彤, 陈康寅. 既往出血性脑卒中患者行经皮冠脉介入治疗后不良事件的危险因素分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 323-329.
[14] 邓越, 白鹏, 洪秋阳, 王桂玲. 颈部七线调衡疗法探析并病例汇报一例[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 345-349.
[15] 唐欣, 翟文海, 王润婷, 周胜宇, 靳航. 补体在缺血性卒中疾病中的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 382-392.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?